MAP1LC3B and neoplasm: Positive LC3b immunoreactivity (HR 0.09, CI 0.01-0.69, p=0.021), higher Gleason score (HR 3.48, CI 1.23-9.88, p=0.019) and higher tumour stage (HR 2.23, CI 1.16-4.29, p=0.017) remained independent prognostic parameters for a PCa specific death.